This report from the publisher provides the latest market data for the Global Tissue Heart Valves Market. Information covered by this report includes:
- unit volumes & pricing forecast from 2020-2025
- analyses of the leading companies, and
- global market share analysis.
This report covers the impact of COVID-19 on tissue heart valve replacement procedures, including a recent forecast from 2020 to 2025. COVID-19 has also impacted leading competitors, such as Abbott, Medtronic, Edwards Lifesciences, LivaNova, CryoLife, and others. The report provides insights into trends, drivers, and limiters of the tissue heart valves market, as well as highlights potential opportunities.
- Edwards Lifesciences